Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Anderson

Showing results (31-40 of 107) with videos related to

Pageof 11
Sort By:
The Journal of Physical Chemistry. A|March 29, 2018
Mechanism of Charged, Neutral, Mono-, and Polyatomic Donor Ligand Coordination to Perchlorinated Cyclohexasilane (Si<sub>6</sub>Cl<sub>12</sub>)Konstantin Pokhodnya, Kenneth Anderson, Svetlana Kilina, et al.
Journal of Medical Microbiology|July 24, 2012
Raoultella planticola bacteraemiaAmy Yichen Hu, Kenneth Anderson Leslie, John Baskette, et al.
American Health & Drug Benefits|August 16, 2014
Salsalate, an old, inexpensive drug with potential new indications: a review of the evidence from 3 recent studiesKenneth Anderson, Lance Wherle, Min Park, et al.
The Oncologist|July 3, 2007
New drugs for myelomaPaul G Richardson, Constantine Mitsiades, Robert Schlossman, et al.
Oncogene|December 4, 2003
Biologic sequelae of c-Jun NH(2)-terminal kinase (JNK) activation in multiple myeloma cell linesTeru Hideshima, Toshiaki Hayashi, Dharminder Chauhan, et al.
American Journal of Hematology|September 13, 2008
ESAs not the culprit: more studies requiredHeinz Ludwig, Kenneth Anderson, Franco Dammacco, et al.
International Journal of Oncology|June 26, 2008
MUC1 oncoprotein promotes growth and survival of human multiple myeloma cellsTakeshi Kawano, Rehan Ahmad, Hiroko Nogi, et al.
The Journal of Physical Chemistry Letters|July 14, 2018
Unraveling Photodimerization of Cyclohexasilane from Molecular Dynamics StudiesYulun Han, Kenneth Anderson, Erik K Hobbie, et al.
Nature Reviews. Clinical Oncology|February 22, 2012
Latest advances and current challenges in the treatment of multiple myelomaAnuj Mahindra, Jacob Laubach, Noopur Raje, et al.
Clinical Lymphoma & Myeloma|October 20, 2005
Emerging trends in the clinical use of bortezomib in multiple myelomaPaul G Richardson, Robert Schlossman, Constantine Mitsiades, et al.
Pageof 11

Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
The Journal of Physical Chemistry. A|March 29, 2018
Mechanism of Charged, Neutral, Mono-, and Polyatomic Donor Ligand Coordination to Perchlorinated Cyclohexasilane (Si<sub>6</sub>Cl<sub>12</sub>)Konstantin Pokhodnya, Kenneth Anderson, Svetlana Kilina, et al.
Journal of Medical Microbiology|July 24, 2012
Raoultella planticola bacteraemiaAmy Yichen Hu, Kenneth Anderson Leslie, John Baskette, et al.
American Health & Drug Benefits|August 16, 2014
Salsalate, an old, inexpensive drug with potential new indications: a review of the evidence from 3 recent studiesKenneth Anderson, Lance Wherle, Min Park, et al.
The Oncologist|July 3, 2007
New drugs for myelomaPaul G Richardson, Constantine Mitsiades, Robert Schlossman, et al.
Oncogene|December 4, 2003
Biologic sequelae of c-Jun NH(2)-terminal kinase (JNK) activation in multiple myeloma cell linesTeru Hideshima, Toshiaki Hayashi, Dharminder Chauhan, et al.
American Journal of Hematology|September 13, 2008
ESAs not the culprit: more studies requiredHeinz Ludwig, Kenneth Anderson, Franco Dammacco, et al.
International Journal of Oncology|June 26, 2008
MUC1 oncoprotein promotes growth and survival of human multiple myeloma cellsTakeshi Kawano, Rehan Ahmad, Hiroko Nogi, et al.
The Journal of Physical Chemistry Letters|July 14, 2018
Unraveling Photodimerization of Cyclohexasilane from Molecular Dynamics StudiesYulun Han, Kenneth Anderson, Erik K Hobbie, et al.
Nature Reviews. Clinical Oncology|February 22, 2012
Latest advances and current challenges in the treatment of multiple myelomaAnuj Mahindra, Jacob Laubach, Noopur Raje, et al.
Clinical Lymphoma & Myeloma|October 20, 2005
Emerging trends in the clinical use of bortezomib in multiple myelomaPaul G Richardson, Robert Schlossman, Constantine Mitsiades, et al.
Pageof 11